Claim: Vaccine-related deaths jumped significantly in the first quarter of 2021 compared with previous years.
Verdict: Missing context
Read the full story at: USA Today
Social Media Disinfo
Circulating on social media: Claim that people become more prone to Covid-19 infection after they receive their first of two vaccine doses.
Read the full story at: Agence France-Presse
Factual Reads on Coronavirus
In rare instances, AstraZeneca’s Covid-19 vaccine linked to blood clots, regulators say
The European Medicines Agency has concluded there is a link between AstraZeneca’s Covid-19 vaccine and “very rare” but dangerous clotting events reported in a number of countries where the vaccine has been used, events which in some cases have been fatal.
-- Stat, April 7
Americans' Worry About Catching COVID-19 Drops to Record Low
At the same time Americans' satisfaction with the rollout of the COVID-19 vaccine has surged, their concerns about getting the virus and about the availability of coronavirus tests and hospital services/treatment have fallen to record lows.
-- Gallup, April 6
If You Don’t Have COVID Vaccine Side Effects, Are You Still Protected?
Reactions reflect unique features of an individual’s immune system, not the strength of a response.
-- Scientific American, April 1
COVID Antibodies May Last Days to Years, Depending on Severity of Infection
Antibodies against SARS-CoV-2 are likely to wane at different rates depending on the severity of the infection, new research suggests.
-- Reuters Health Information, via Medscape, March 31
Moderna and Pfizer COVID-19 vaccines may block infection as well as disease
Studies suggest fully vaccinated people pose a low risk for transmitting the coronavirus.
-- ScienceNews, March 30
A rare clotting disorder may cloud the world's hopes for AstraZeneca's COVID-19 vaccine
[T]he vaccine faces new concerns about safety as an explanation gains ground for the unusual strokes and clotting disorders recorded in at least 30 recipients.
-- Science, March 27
The Coronavirus Variants Don't Seem to Be Highly Variable So Far
SARS-CoV-2 may be settling into a limited set of mutations.
-- Scientific American, March 24
U.S. health body questions AstraZeneca's COVID-19 vaccine trial data
AstraZeneca may have released outdated information on its latest COVID-19 vaccine trial, giving an “incomplete” picture of its efficacy, a leading U.S. health agency said on Tuesday, casting doubt on the shot’s potential U.S. rollout and plunging its developers, once again, into controversy.
-- Reuters, March 23
AstraZeneca: US data shows vaccine effective for all ages
AstraZeneca’s COVID-19 vaccine provided strong protection against sickness and eliminated hospitalizations and deaths from the disease across all age groups in a late-stage study in the United States, the company announced Monday.
-- Associated Press, March 22
The Best Coronavirus Myth-Busting Collections